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Abstract
Objectives Computed tomography (CT) pulmonary angiography is widely used in patients with suspected pulmonary hyperten-
sion (PH). However, the diagnostic and prognostic significance remains unclear. The aim of this study was to (a) build a
diagnostic CT model and (b) test its prognostic significance.
Methods Consecutive patients with suspected PH undergoing routine CT pulmonary angiography and right heart catheterisation
(RHC) were identified. Axial and reconstructed images were used to derive CT metrics. Multivariate regression analysis was
performed in the derivation cohort to identify a diagnostic CT model to predict mPAP ≥ 25 mmHg (the existing ESC guideline
definition of PH) and > 20 mmHg (the new threshold proposed at the 6th World Symposium on PH). In the validation cohort,
sensitivity, specificity and compromise CT thresholds were identified with receiver operating characteristic (ROC) analysis. The
prognostic value of the CT model was assessed using Kaplan-Meier analysis.
Results Between 2012 and 2016, 491 patients were identified. In the derivation cohort (n = 247), a CT model was identified
including pulmonary artery diameter, right ventricular outflow tract thickness, septal angle and left ventricular area. In the
validation cohort (n = 244), the model was diagnostic, with an area under the ROC curve of 0.94/0.91 for mPAP ≥ 25/>
20 mmHg respectively. In the validation cohort, 93 patients died; mean follow-up was 42 months. The diagnostic thresholds
for the CT model were prognostic, log rank, all p < 0.01.
Discussion In suspected PH, a diagnostic CT model had diagnostic and prognostic utility.
Key Points
• Diagnostic CT models have high diagnostic accuracy in a tertiary referral population of with suspected PH.
• Diagnostic CT models stratify patients by mortality in suspected PH.
Keywords Hypertension, pulmonary . Pulmonary artery . Heart ventricles . Diagnostic imaging
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Introduction
Pulmonary hypertension (PH) has been defined arbitrarily as a
mean pulmonary artery pressure of at least 25mmHg at rest [1].
However, data from normal subjects have suggested that a
mean pulmonary artery pressure in excess of 20 mmHg is ab-
normal [2]. The 6th World Symposium on PH has therefore
proposed a threshold of > 20mmHg to define PH and a require-
ment for a pulmonary vascular resistance of at least 3 Wood
Units to define pre-capillary PH. PH has many causes and its
presence is associated with a high morbidity and a high mortal-
ity [3]. Due to the non-specificity of symptoms, PH is often
diagnosed late. Given the availability of therapies for specific
forms of PH, there is increasing interest in better patient phe-
notyping and improving diagnostic rates with imaging [4].
Transthoracic Doppler echocardiography is a non-invasive
test, which is widely available, is relatively inexpensive and is
recommended in international guidelines if the diagnosis of
PH is suspected [1]. In a meta-analysis of diagnostic studies,
the pooled sensitivity for the diagnosis of PH was 88% (84–
92) and specificity was 56% (46–66) [5]. In patients with
obesity or lung disease, views of the tricuspid regurgitant jet
and cardiac chambersmay be inadequate [6, 7]. A recent study
has shown that, in a large population of patients undergoing
echocardiography, tricuspid regurgitant jet velocity can be
measured in 50% of patients [8]. More recently, there has been
interest in the role of MRI techniques to identify patients with
PH and a number of features visible on MRI such as elevated
ventricular mass index [9–11], reduced pulmonary artery
pulsatility [12, 13] and pulmonary flow [14, 15] may suggest
the diagnosis of PH. However, MRI is expensive and less
available than other imaging modalities. Right heart catheter-
isation (RHC) is the gold standard test for pressure measure-
ment and thus diagnosis of PH.
Computed tomography has been seen to have several tech-
nological advances over the last three decades, and the intro-
duction of iterative reconstruction CT algorithms has led to a
significant reduction in image noise and radiation dose [16]. CT
is frequently used in the evaluation of breathlessness and in the
assessment of lung and increasingly cardiac disease [17–24].
The majority of studies using CT as a diagnostic tool have
concentrated primarily on pulmonary artery size. However, re-
modelling of the cardiac chambers and bowing of the
interventricular septum can also be detected on CT pulmonary
angiography [18, 19, 25–27] in patients with PH. The aim of
this study was to (a) build a diagnostic CT model in patients
with suspected PH using the current guideline definition of PH
(mPAP ≥ 25 mmHg) and the recent proposed definition of
> 20 mmHg, and (b) test its prognostic significance.
Materials and methods
Patients
Consecutive treatment-naïve patients with suspected PH re-
ferred to a nationally designated PH centre (Sheffield
Pulmonary Vascular Disease Unit) between April 2012 and
March 2016 were identified from the ASPIRE Registry MRI
database [28]. Inclusion criteria required CT pulmonary angi-
ography to be performed within 90 days of RHC. All patients
underwent MRI within 48 h of RHC. Ethical approval for this
analysis of imaging techniques and routinely collected data
was granted by our institutional review board.
CT pulmonary angiography acquisition
All CT pulmonary angiograms in Sheffield were performed
on a light-speed 64-slice MDCT scanner (GE Healthcare).
Standard acquisition parameters were used: 100 mAwith au-
tomated dose reduction, 120 kV, pitch 1, rotation time 0.5 s
and 0.625 mm collimation. A 400mm× 400mm field of view
was used with an acquisition matrix of 512 × 512. One hun-
dred millilitres of intravenous contrast agent (Ultravist, Bayer)
was administered at a rate of 5 mL/s. HRCTs were recon-
structed using the contrast-enhanced acquisitions with
1.25 mm collimation from the apex of the lung to the dia-
phragm. Inclusion criteria for studies performed outside of
Sheffield included CT pulmonary angiography with volumet-
ric coverage of the pulmonary vasculature and cardiac struc-
tures and reconstructed slice thickness of 2 mm or less.
CT image analysis
Vessel measurements
Main pulmonary artery (PA) diameter was measured perpen-
dicular to the vessel axis at the widest point. At the same level
as the main PA measurement, the diameter of the ascending
and descending aorta was recorded and the pulmonary artery
to aortic ratio was calculated (Fig. 1a). Right and left main
pulmonary artery diameters were measured at the widest
point. The IVC diameter was measured just below the entry
level to the right atrium. The extent of hepatic reflux was
measured using an adapted 4 grade score of regurgitation.
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Cardiac measurements
Maximal biventricular areas and diameters (mid-ventricular)
and atrial areas were manually traced on axial images. Slices
were chosen to ensure the greatest area or diameter was mea-
sured. Ventricle and atrial diameters were measured on the
same slices as area measurements. Ventricular muscle area
and circumference walls were measured for both right and left
ventricles. The muscular thickness of the RVoutflow tract was
measured anteriorly ~ 1 cm below the pulmonary valve
(Fig. 1b). Maximal LV area is shown in Fig. 1d and maximal
RVand LV diameters are shown in Fig. 1e and f respectively.
Reconstructed short-axis images
Images were reconstructed using multi-planar reformat soft-
ware (IMPAX, volume viewer, Agfa HealthCare) to generate
a mid-chamber short-axis image and 4-chamber image. On the
short-axis image, the interventricular septal angle was
measured, defined as the angle from the RV insertion points
to the mid-interventricular septum (Fig. 1c). On the recon-
structed 4-chamber image, biventricular areas and diameters
(mid-ventricular) and atrial areas were manually traced.
MR image acquisition and analysis methods and details on
right heart catheterisation are found in the Supplementary
Methods.
Statistics
Normal distributionwas assessed through visual and statistical
analysis, using histograms and quantile-quantile (Q-Q) plots
as a way of determining normality of all variables. Where
appropriate, continuous data was presented with mean and
standard deviation. Group comparison of continuous data
was made using independent t test and categorical group com-
parisons was made using chi-square and Fisher’s exact test.
Correlations between CT measurement and mPAP, PVR and
cardiac MRI data were made using Pearson’s correlation test.
Fig. 1 Multi-figure CT images
illustrating the CT measurements
in a patient with PH with severe
elevation of pulmonary artery
pressure. Illustrations show the
measurement of pulmonary artery
and aortic diameter (a), right
ventricular outflow tract thickness
(b), interventricular septal angle
(c) (reconstructed short-axis im-
ages) and left ventricular area (d).
Images e and f illustrate the mea-
surements required to calculate
the RV/LV diameter ratio maxi-
mal RV diameter (e) and maximal
LV diameter (f)
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Derivation and validation cohorts were identified using ran-
dom number generation. CT variables significant at indepen-
dent t test or chi-square at univariate analysis (p < 0.05) in the
derivation cohort were entered into a binary logistic regression
model using forward stepwise selection. CT diagnostic model
Awas the resultant model. Sensitive, compromise and specific
diagnostic thresholds were identified in the derivation cohort
by visual inspection of ROC curves. In the validation cohort,
the derived thresholds were tested using the 2 × 2 contingency
table to determine sensitivity, specificity and positive and neg-
ative predictive values. A secondmodel, CT diagnostic model
B, was developed without septal angle; septal angle is the only
measurement that requires image reconstruction, and some
observers will not have access to a reconstruction tool when
reporting or in situations where there is limited time; therefore,
we elected to develop a model that could be used on the axial
images alone.
The prognostic value of CT sensitive, compromise and
specific diagnostic thresholds and right heart catheterisation
thresholds of ≥ 25 mmHg and > 20 mmHgwas assessed using
Kaplan-Meier and Cox proportional hazards regression anal-
ysis. The intra-class correlation co-efficient (ICC) was used to
test the reproducibility of CT metrics. IBM SPSS Statistics 22
was used to perform the statistical analysis. A p value of
< 0.05 was considered statistically significant.
Results
Between April 2012 and March 2016, 840 consecutive treat-
ment-naïve patients with suspected PH were identified who
underwent MRI and RHC, of whom 491 patients underwent
CT pulmonary angiography within 90 days. Patients
underwent CT imaging at 68 different institutions and 78%
of CT pulmonary angiograms were performed at the Sheffield
Pulmonary Vascular Disease Unit. Patient demographics,
RHC and CT metrics for patients with PH (n = 420), with
mPAP < 25 mmHg (n = 71) and with mPAP ≤ 20 mmHg are
shown in Table 1. Patients with PH were older (p < 0.001) and
more likely to be female (p < 0.013) and have a higher WHO
functional class (p < 0.001) and lower walking distance
(p < 0.001), than patients without PH. Correlation of CT met-
rics with mPAP and PVR is presented in Supplementary
Table 1 and key correlations are in Fig. 2. Table 2 presents
the sensitivity, specificity and positive and negative predictive
value of pulmonary artery diameter, right ventricular outflow
tract thickness, interventricular septal angle and RV/LV diam-
eter ratio.
Derivation cohort
Random patient selection identified a derivation cohort of 247
and a validation cohort of 244 patients. There were no
significant differences in age, proportion of patients with
PH, WHO functional class or right heart catheterisation met-
rics between the two cohorts (p > 0.05). However, there was a
higher proportion of females in the derivation cohort as com-
pared with the validation cohort (Supplementary Table 2).
CT diagnostic model A
In the derivation cohort, a regression model was identified.
The model incorporated main pulmonary artery diameter,
right ventricle outflow tract thickness, left ventricular area
and interventricular septal angle as follows: model A score =
− 14.299 + (0.192 × main pulmonary artery diameter, mm) +
(0.518 × right ventricle outflow tract thickness, mm) − (0.001
× left ventricular area, mm2) + (0.068 × interventricular septal
angle, degrees). The area under the curve (AUC) in the deri-
vation cohort was 0.92 (see Fig. 3). The AUC in the derivation
cohort with adjustment for body surface area was 0.86. The
following thresholds were identified in the derivation cohort:
high sensitivity (model A score 0), high specificity (model A
score 2.5) and a compromise threshold (model A score 1.25).
The diagnostic model performed better than individual CT
metrics. Of the individual CTmetrics, the AUC for pulmonary
artery diameter was 0.79, right ventricular outflow tract thick-
ness 0.79, left ventricular area 0.64 and interventricular septal
angle 0.84.
For the prediction of mPAP > 20 mmHg, a model of
− 13.843 + (0.94 × right ventricle outflow tract thickness,
mm) + (0.094 × interventricular septal angle, degrees) was
identified. The diagnostic accuracy of this model was AUC
0.88 for detecting mPAP > 20 mmHg; this was of lower accu-
racy in comparison with model A that had a diagnostic accu-
racy of 0.90 for detecting mPAP > 20 mmHg.
CT diagnostic model B
In the derivation cohort, a second model was developed; the
model incorporated main pulmonary artery diameter, right
ventricle outflow tract thickness and RV/LV diameter ratio,
as follows: model B score = − 9.181 + (0.174 × main pulmo-
nary artery diameter, mm) + (0.480 × right ventricle outflow
tract thickness, mm) + (2.539 × RV/LV diameter, ratio). This
model had an AUC of 0.89 in the derivation cohort. The
following thresholds were identified in the derivation cohort:
high sensitivity (model B score 0.5), compromise threshold
(model B score 1.0) and a high specificity threshold (model B
score 1.5) (see Table 4). CT diagnostic prediction model to
detect mPAP > 20 mmHg was also derived: − 4.553 + (0.661
× right ventricle outflow tract thickness, mm) + (3.027 × RV/
LV diameter, ratio). This model had lower accuracy for pre-
diction of mPAP > 20 mmHg at ROC analysis: AUC 0.86
compared with 0.89 for model B.
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Table 1 Demographics of patients with and without PH for the full cohort
Covariates No PH, mPAP ≤ 20 mmHg,
n = 36
No PH, mPAP < 25 mmHg,
n = 71
PH, mPAP ≥ 25 mmHg,
n = 420
p value < 25 vs
≥ 25 mmHg
Demographics
Age (years) 61 (14) 60 (15) 65 (13) < 0.001
Sex % female 69% 58% 0.013
BSA (m2) 1.8 (0.2) 1.86 (0.27) 1.83 (0.23) 0.377
WHO FC % (1/2/3/4) 0/18/17/1 0/49/50/1 0/7/83/10 < 0.001
ISWT
Distance (m) 346 (211) 315 (203) 206 (187) < 0.001
RHC
mRAP (mmHg) 5 (3) 6 (3) 11 (6) < 0.001
mPAP (mmHg) 17 (2) 20 (3) 45 (13) < 0.001
PAWP (mmHg) 9 (5) 11 (5) 13 (5) < 0.001
Cardiac output (L/min) 5.5 (1.4) 5.7 (1.5) 4.8 (1.5) < 0.001
Cardiac index (L/min/m2) 3.0 (0.8) 3.1 (0.8) 2.6 (0.8) < 0.001
PVR (dyns) 120 (1250) 138 (102) 603 (385) < 0.001
Computed tomography
Right heart metrics
RA area 2085 (659) 2263 (1152) 3108 (1144) < 0.001
RV diameter (mm) 36 (7.7) 38 (8.1) 45 (9.1) < 0.001
RV muscle wall area (mm2) 247 (114) 272 (117) 416 (184) < 0.001
RV chamber area (mm2) 2084 (658) 2272 (766) 3005 (918) 0.011
RVoutflow tract (mm) 4.8 (1.2) 4.9 (1.4) 7.0 (1.9) 0.004
Septal angle (degrees) 129 (7.2) 132 (9.5) 151 (14.2) < 0.001
Left heart metrics
LA area (mm2) 1967 (479) 2095 (632) 2165 (768) 0.47
LV chamber area (mm2) 2256 (656) 2405 (707) 2123 (704) 0.002
LV muscle area (mm2) 1549 (357) 1618 (396) 1586 (450) 0.584
Ratios
RA area/LA area ratio 1.0 (0.3) 1.1 (0.39) 1.6 (1.46) 0.003
RV diameter/LV diameter 1.0 (0.2) 0.95 (0.25) 1.33 (0.46) < 0.001
RV muscle area/LV muscle area 0.16 (0.08) 0.17 (0.77) 0.28 (0.14) < 0.001
RV chamber area/LV chamber
area
1.0 (0.3) 0.99 (0.38) 1.56 (0.75) < 0.001
Vessel measurements
Main PA diameter (mm) 26 (4) 26 (4.0) 33 (5.3) 0.07
Main PA/ascending aorta ratio
(ratio)
0.84 (0.13) 0.87 (0.17) 1.05 (0.19) < 0.001
Main PA/descending aorta ratio
(ratio)
1.17 (0.20) 1.2 (0.22) 1.43 (0.30) < 0.001
Left PA diameter (mm) 21.1 (4.1) 22 (3.6) 25 (3.7) < 0.001
Right PA diameter (mm) 21.9 (4.3) 22 (4.4) 26 (4.4) < 0.001
Inferior vena cava area (mm2) 525 (144) 579 (209) 639 (207) 0.023
Superior vena cava area (mm2) 305 (80) 320 (104) 382 (134) < 0.001
Hepatic reflux of contrast (score
0 to 3)
0 (18), 1 (13), 2 (3),
3 (1)
0 (35), 1 (24), 2 (7)
and 3 (4)
0 (128), 1 (117), 2 (98)
and 3 (73)
< 0.001
BSA, body surface area; WHO FC, World Health Organisation functional class; mRAP, mean right atrial pressure; mPAP, mean pulmonary arterial
pressure; PAWP, pulmonary arterial wedge pressure; PVR, pulmonary vascular resistance; RA, right atrium; RV, right ventricle; LA, left atrium; LV, left
ventricle; PA, pulmonary artery
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Validation cohort
Identification of patients with mPAP greater than or equal
to 25 mmHg
CT diagnostic model A In the validation cohort, the CT
diagnostic model A showed high diagnostic accuracy for
the detection of PH (AUC at 0.94; Fig. 3). The CT diag-
nostic model A adjusted for BSA did not improve the
diagnostic performance of the model (AUC 0.92).
Sensitivity, specificity and positive and negative predic-
tive values are presented for high sensitivity, specificity
and compromise thresholds in Table 3.
CT diagnostic model BModel B was derived excluding the
single parameter that required reconstruction (interventric-
ular septal angle). In the validation cohort, diagnostic CT
model B had an accuracy of 0.92. Table 3 details the
sensitivity, specificity and positive and negative predictive
values for high sensitivity, specificity and compromise
thresholds.
Identification of patients with mPAP greater than 20 mmHg
CT diagnostic model A In the validation cohort, the CT diag-
nostic model A showed high diagnostic accuracy for the de-
tection of PH (AUC at 0.91). The CT diagnostic model A
adjusted for BSA marginally improved the diagnostic perfor-
mance of the model (AUC 0.93).
CT diagnostic model B Model B was derived excluding the
single parameter that required reconstruction (interventricular
septal angle). In the validation cohort, diagnostic CT model B
was marginally weaker than model A with an accuracy of
0.87.
Table 4 details the sensitivity, specificity and positive and
negative predictive values for high sensitivity, specificity and
Fig. 2 Correlations of mean
pulmonary arterial pressure with
main pulmonary artery diameter
(a), right ventricular outflow tract
thickness (RVOT) (b), interven-
tricular septal angle (c), left ven-
tricular (LV) area (d) and RV/LV
diameter ratio (e). f Correlation
between septal angle and RV/LV
diameter ratio
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compromise thresholds for identification of patients with
mPAP greater than or equal to 20 mmHg.
Prognostic significance of CT and right heart catheterisation
thresholds
CT diagnostic model A In the validation cohort, 93 patients
died; mean follow-up was 42 months. The CT diagnostic
model A sensitive (0), compromise (1.25) and (2.5) specific
thresholds for mPAP ≥ 25 mmHg were strongly predictive of
mortality log rank 11.13 (p = 0.0009 and 9.70; p = 0.002 and
9.49; p = 0.002 respectively). The CT diagnostic model A
sensitive (0), compromise (1.0) and (2.25) specific thresholds
for mPAP > 20 mmHg were also strongly predictive of mor-
tality log rank 11.13 (p = 0.0009 and 6.25; p = 0.010 and
10.57; p = 0.001).
CT diagnostic model B The CT diagnostic model B sensitive
(0.5), compromise (1.0) and (1.5) specific thresholds for
mPAP ≥ 25 mmHg were as follows (mortality log rank
6.92): p = 0.009 and 3.25; p = 0.071 and 6.28; p = 0.012 re-
spectively. The CT diagnostic model B sensitive (0.5), com-
promise (0.8) and (1.4) specific thresholds for mPAP
> 20 mmHg were also strongly predictive of mortality log
rank 6.92 (p = 0.009 and 6.56; p = 0.010 and 535; p = 0.021).
At Cox regression analysis, CT diagnostic models A and B
were prognostic; z score hazard ratios were 1.56 and 1.42,
both p < 0.0001.
Table 2 Diagnostic accuracy of
predictive thresholds for PA
diameter, RVOT thickness, septal
angle and RV diameter/LV diam-
eter ratio in the validation cohort
Thresholds Sensitivity Specificity Positive predictive
value
Negative predictive
value
p value
PA diameter
Sensitive ≥ 28 mm 90 71 95 50 < 0.001
Compromise
≥ 30 mm
75 81 96 32 < 0.001
Specific ≥ 32 mm 58 90 98 24 < 0.001
RVOT thickness
Sensitive ≥ 5 mm 95 42 92 57 < 0.001
Compromise
≥ 6 mm
80 77 96 36 < 0.001
Specific ≥ 7 mm 55 97 99 24 < 0.001
Septal angle
Sensitive ≥ 130 93 35 91 42 < 0.001
Compromise
≥ 140
78 97 99 39 < 0.001
Specific ≥ 150 51 97 99 22 < 0.001
RV diameter/LV diameter
Sensitive ≥ 0.8 89 19 88 20 0.2375
Compromise ≥ 1 72 58 92 24 0.0015
Specific ≥ 1.2 50 90 97 21 < 0.001
PA, pulmonary artery; RVOT, right ventricle outflow tract; RV, right ventricle; LV, left ventricle
Fig. 3 Receiver operating characteristic analysis in a derivation cohort
and validation cohort for diagnostic model A for prediction of mPAP ≥
25 mmHg
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Right heart catheter diagnostic thresholds RHC diagnostic
thresholds ≥ 25 mmHg and > 20 mmHg were not prognostic
in this cohort (log rank 2.86, p = 0.09 and log rank 1.77, p =
0.18 respectively; see Fig. 4).
Correlations and diagnostic value of individual CT
metrics with pulmonary haemodynamics and MRI
metrics in the full cohort
Correlations between CT vascular and cardiac measures are
shown in Supplementary Table 1. Figure 2 shows the correla-
tion of CT metrics and mean pulmonary artery pressure. A
detailed description of the MRI findings is found in
Supplementary Results.
Reproducibility
High reproducibility of interventricular septal angle (ICC
0.921), pulmonary artery diameter (ICC 0.954) and left ven-
tricular area (ICC 0.953) was demonstrated. In comparison,
good reproducibility was recorded for the variables RV/LV
diameter ratio (ICC 0.810) and right ventricular outflow tract
thickness (ICC 0.76) (see Table 5).
Discussion
In this study, we have shown that CT diagnostic models com-
bining multiple metrics are superior to individual metrics in
predicting the likelihood of PH. We have created models that
utilise axial and reconstructed images and have also developed
pragmatic scoring systems based on axial only images to im-
prove the accessibility of CT to both radiologists and physi-
cians. This approach could be used to increase or reduce the
pre-test probability of PH. In addition, the CT diagnostic mod-
el had prognostic value with a negative score particularly at
the sensitive threshold, indicating excellent survival.
Regression analysis identified pulmonary artery diameter,
right ventricular outflow tract thickness, left ventricular area
and interventricular septal angle as having additive value for
the diagnosis of PH (CT diagnostic model A). Using a thresh-
old of ≥ 0 units had a sensitivity of 96% and specificity of
58%, whereas a threshold of ≥ 2.5 units had a sensitivity of
71% and specificity of 100% in the validation cohort. An
alternative model (CT diagnostic model B), utilising measure-
ments from axial images alone, pulmonary artery diameter,
right ventricular outflow tract thickness and the RV/LV diam-
eter ratio, although marginally weaker also had good diagnos-
tic accuracy. This model may provide a practical alternative if
Table 4 Regression CT diagnostic models A and B thresholds and their accuracy for predicting the presence of patients with mPAP greater than
20 mmHg in the validation cohort
Thresholds Sensitivity Specificity Positive predictive
value
Negative predictive
value
p value
Diagnostic model A
Sensitive ≥ 0 units 93 67 98 38 < 0.001
Compromise ≥ 1 units 82 80 98 22 < 0.001
Specific ≥ 2.25 units 67 100 100 17 < 0.001
Diagnostic model B
Sensitive ≥ 0.5 units 87 67 98 25 < 0.001
Compromise ≥ 0.8 units 82 90 98 23 < 0.001
Specific ≥ 1.4 units 72 80 98 16 < 0.001
Table 3 Regression CT diagnostic models A and B thresholds and their accuracy for predicting the presence of PH in the validation cohort
Thresholds Sensitivity Specificity Positive predictive value Negative predictive value p value
Diagnostic model A
Sensitive ≥ 0 units 96 58 94 69 < 0.001
Compromise ≥ 1.25 units 82 84 97 41 < 0.001
Specific ≥ 2.5 units 71 100 100 33 < 0.001
Diagnostic model B
Sensitive ≥ 0.5 units 92 71 96 55 < 0.001
Compromise ≥ 1 units 84 81 97 42 < 0.001
Specific ≥ 1.5 units 75 90 98 35 < 0.001
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reconstruction tools are not available when reviewing CT im-
ages. In this model, a score of ≥ 0.5 units had a sensitivity of
92% and specificity of 71%, whereas a score of ≥ 1.5 units had
a sensitivity of 75% and specificity of 90%.
The most commonly measured vessel on CT pulmonary
angiograms in suspected PH is the pulmonary artery. The
Framingham study established a reference range for normal
and established 27 mm and 29 mm as representing the upper
limits of normal for female and male patients, respectively.
Previous studies using pulmonary artery size to diagnose PH
have shown that a pulmonary artery diameter greater than
29 mm had a sensitivity of 75% and specificity of 89% for
the presence of PH [29]. The utility of measuring the main
pulmonary artery diameter and the pulmonary artery to aortic
ratio has also been studied in suspected PH. Ng et al found that
a pulmonary artery to aortic ratio > 1 was 92% specific for a
mPAP > 20 mmHg [30]; other reports indicate diagnostic val-
ue in suspected PH [31, 32]. However, the pulmonary artery
may be enlarged in the absence of PH and increases in pul-
monary artery size over time are a feature of PH and are not
necessarily an indication of increasing pulmonary artery pres-
sure; as such, the correlation with mPAP is weak [33].
Although some investigators have suggested that pulmonary
artery diameter may be unreliable in patients with underlying
interstitial lung disease [34], we have recently shown that PA
size has equivalent diagnostic utility in all patients with
suspected PH and interstitial lung disease [35]. The present
study confirms pulmonary artery diameter as an independent
predictor of the presence of PH. We identified three thresh-
olds: ≥ 28 mm as sensitive, ≥ 30 mm as a compromise and ≥
32 mm as a specific threshold. These three thresholds can be
used depending on the clinical scenario. Of CT measures
used, the pulmonary artery diameter was the most reproduc-
ible. PA diameter, however, did not prove to be a significant
independent predictor of patients with PH defined bymPAP ≥
20 mmHg. We suspect this is due to underpowering based on
Fig. 4 Prognostic significance of
CT model A showing CT
thresholds ((a) sensitive threshold
and (b) compromise threshold)
and mPAP thresholds ((c) mPAP
≥ 25 mmHg and (d) mPAP >
20 mmHg)
Table 5 Reproducibility tests of
the variables selected in model Covariates Intra-class correlation Upper 95% CI Lower 95% CI p value
Septal angle 0.921 0.973 0.769 < 0.001
PA diameter 0.954 0.988 0.710 < 0.001
RVoutflow tract 0.760 0.920 0.263 0.007
LVarea 0.953 0.984 0.862 < 0.001
RV/LV diameter ratio 0.810 0.447 0.936 0.002
PA, pulmonary artery; RV, right ventricle; LV, left ventricle
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the small number of patients with mPAP < 20 mmHg; further
work in populations with larger number of patients with mild
disease is required to better develop a predictive model for
identification of patients with mPAP ≥ 20 mmHg.
Interventricular septal angle also showed strong diagnostic
value and, when increased, had high specificity for the presence
of PH. In the present study, CT images were reconstructed into
the short-axis plane and a moderate correlation was identified
with mPAP (r = 0.62), though weaker than that identified previ-
ously using MRI-derived systolic septal angle (r = 0.82) [36].
However, in this population, the diagnostic accuracy of CT sep-
tal angle was similar to that of MRI-derived systolic septal angle
[11], which was an unexpected finding given the non-gated
nature of CT. This may reflect the impact of RV enlargement
and pressure overload both in diastole and systole which is seen
frequently in the setting of significant pre-capillary disease.
However, gating may be more important whenminor elevations
of pulmonary artery pressure are being investigated. Min et al
also studied CT septal angle using ungated CT pulmonary an-
giography demonstrating a close correlation with pulmonary
vascular resistance with high accuracy for detecting elevated
PVR [21]. Septal angle may also have a role in the identification
of patients with combined pre- and post-capillary PH, which has
been demonstrated using MRI [37]. The ratio of the right ven-
tricular to left ventricular diameter has prognostic value in PAH
[17] and we have also demonstrated diagnostic value in this
study. However, using reconstructed short-axis images to calcu-
late septal angle, rather than using this ratio, improved diagnos-
tic certainty. The ratio of the right ventricular to left ventricular
diameter, however, still provides additional diagnostic value
when added to pulmonary artery size and right ventricular out-
flow tract diameter and should be combined with these mea-
sures, when images cannot be reconstructed, to improve the
diagnostic performance of CT pulmonary angiography.
The musculature of the right ventricular outflow tract is
compacted and subjectively easier to measure than the
trabeculated right ventricular free wall. Hence, it is not unexpect-
ed that the outflow tract thickness had higher diagnostic accuracy.
Nonetheless, of all the metrics used in the diagnostic models, the
right ventricular outflow tract thickness was the least reproduc-
ible. Right ventricular mass measured by MRI has also been
shown previously to increase with pulmonary arterial pressure
[9, 10]. This study has also examined the correlation of CT
metrics with pulmonary haemodynamics. Septal angle had the
highest correlation with mean pulmonary artery pressure of any
of the CTmetrics (r= 0.62) and was superior to RV/LV diameter
ratio, demonstrating the value of reconstructing images.
Limitations
The CTscans were not cardiac-gated, but despite this, CT mea-
surements still had diagnostic value. Cardiac-gated CT allows
for imaging of specific stages during a cardiac cycle and
reduces cardiac motion artefacts seen in a CTPA and would
help capture maximal deviation of the interventricular septum
and volumetric metrics in future studies. Positive and negative
predictive values will differ depending on the diagnostic set-
ting; here, we show data from a tertiary referral centre popula-
tion of patients with PH with a high pre-test probability of PH.
This data may be particularly helpful when triaging patients
with suspected severe PH for consideration of targeted pulmo-
nary vascular therapies, although the diagnostic performance of
CT in a community diagnostic setting has not been assessed.
Conclusions
This study has developed and validated predictive thresholds
using a combination of CT metrics in separate derivation and
validation cohorts. Sensitive and specific thresholds have been
identified that may be of value in both screening and for more
definitive diagnosis depending on the clinical scenario. The
diagnostic CT thresholds are also of prognostic value; patients
found not to have PH on CT have an excellent outcome.
Given the widespread use of CT to investigate unexplained
breathlessness, a more systematic approach to CT evaluation
may improve PH diagnostic rates.
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